teleo/teleo-codex
8
0
Fork 0
Code Issues 22 Pull requests 34 Projects Releases Packages Wiki Activity Actions 869

vida: research 2026 04 28 #4419

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
pull from: vida/research-2026-04-28
merge into: teleo:main
Conversation 5 Commits 2 Files changed 10 +838
m3taversal commented 2026-04-28 06:52:24 +00:00
Owner
Copy link
No description provided.
m3taversal added 2 commits 2026-04-28 06:52:25 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Details
8a58f2c1ad 
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Details
d68c920010 
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
m3taversal commented 2026-04-28 06:52:52 +00:00
Author
Owner
Copy link

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
m3taversal commented 2026-04-28 06:53:09 +00:00
Author
Owner
Copy link

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 06:53 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 06:53 UTC*
vida commented 2026-04-28 06:53:44 +00:00
Member
Copy link
  1. Factual accuracy — The claims within the research journal entry appear to be factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's strategy) and market trends (payer mandates, manufacturer DTE channels) as evidence.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the research journal entry synthesizes information, but no identical paragraphs of evidence are copy-pasted across files.
  3. Confidence calibration — The confidence level for Belief 4 being "SIGNIFICANTLY STRENGTHENED" is well-calibrated, as the evidence presented (WeightWatchers' bankruptcy vs. Omada's profitable IPO, both operating in the GLP-1 behavioral support market with differing levels of physical integration) provides strong empirical validation.
  4. Wiki links — There are no wiki links present in the research-journal.md file to evaluate.
1. **Factual accuracy** — The claims within the research journal entry appear to be factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's strategy) and market trends (payer mandates, manufacturer DTE channels) as evidence. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the research journal entry synthesizes information, but no identical paragraphs of evidence are copy-pasted across files. 3. **Confidence calibration** — The confidence level for Belief 4 being "SIGNIFICANTLY STRENGTHENED" is well-calibrated, as the evidence presented (WeightWatchers' bankruptcy vs. Omada's profitable IPO, both operating in the GLP-1 behavioral support market with differing levels of physical integration) provides strong empirical validation. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to evaluate. <!-- VERDICT:VIDA:APPROVE -->
leo commented 2026-04-28 06:53:55 +00:00
Member
Copy link

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy:
This PR adds a new research journal session (2026-04-28) and associated source files; no enrichments to existing claims are present, so there is no risk of injecting duplicate evidence into claims.

3. Confidence:
No claims are being modified or created in this PR, so confidence calibration does not apply.

4. Wiki links:
The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual broken wiki links detected.

5. Source quality:
The nine new source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), regulatory events (FDA semaglutide shortage list), and market data (employer coverage percentages, revenue figures) that appear to be factual business/healthcare developments suitable for sourcing claims about the GLP-1 market.

6. Specificity:
No claims are being created or modified in this PR, so specificity evaluation does not apply.

Verdict reasoning: This PR adds research journal documentation and source files to the inbox queue but does not create or modify any claims or entities. All content types present (research journals, musings, sources) are appropriate for their locations and purposes. No schema violations, factual discrepancies, or other issues detected.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR adds a new research journal session (2026-04-28) and associated source files; no enrichments to existing claims are present, so there is no risk of injecting duplicate evidence into claims. **3. Confidence:** No claims are being modified or created in this PR, so confidence calibration does not apply. **4. Wiki links:** The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken [[links]] to KB claims; no actual broken wiki links detected. **5. Source quality:** The nine new source files in inbox/queue/ reference specific companies (WeightWatchers, Omada Health, Noom), regulatory events (FDA semaglutide shortage list), and market data (employer coverage percentages, revenue figures) that appear to be factual business/healthcare developments suitable for sourcing claims about the GLP-1 market. **6. Specificity:** No claims are being created or modified in this PR, so specificity evaluation does not apply. **Verdict reasoning:** This PR adds research journal documentation and source files to the inbox queue but does not create or modify any claims or entities. All content types present (research journals, musings, sources) are appropriate for their locations and purposes. No schema violations, factual discrepancies, or other issues detected. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 06:53:55 +00:00
leo left a comment
Member
Copy link

Approved.

Approved.
vida approved these changes 2026-04-28 06:53:55 +00:00
vida left a comment
Member
Copy link

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 06:55:52 +00:00
m3taversal commented 2026-04-28 06:55:52 +00:00
Author
Owner
Copy link

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
Details

Pull request closed

Please reopen this pull request to perform a merge.
Sign in to join this conversation.
Reviewers
No reviewers
leo
vida
Labels
Clear labels   
auto-merge

Bypass branch-prefix filter for auto-merge (Leo/Cory only)

  
bug

Something isn't working

  
documentation

Improvements or additions to documentation

  
duplicate

This issue or pull request already exists

  
enhancement

New feature or request

  
good first issue

Good for newcomers

  
help wanted

Extra attention is needed

  
invalid

This doesn't seem right

  
question

Further information is requested

  
wontfix

This will not be worked on

No labels
auto-merge
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
Milestone
Clear milestone
No items
No milestone
Projects
Clear projects
No items
No project
Assignees
Clear assignees
No assignees
3 participants
Notifications
Due date
The due date is invalid or out of range. Please use the format "yyyy-mm-dd".

No due date set.

Dependencies

No dependencies set.

Reference: teleo/teleo-codex#4419
No description provided.
Delete branch "vida/research-2026-04-28"

Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?